awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33633424-8FCDF4AE-F8F1-405B-8FDB-6F8E6EBF1046
Q33633424-8FCDF4AE-F8F1-405B-8FDB-6F8E6EBF1046
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33633424-8FCDF4AE-F8F1-405B-8FDB-6F8E6EBF1046
Oral anticancer drugs: how limited dosing options and dose reductions may affect outcomes in comparative trials and efficacy in patients.
P2860
Q33633424-8FCDF4AE-F8F1-405B-8FDB-6F8E6EBF1046
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33633424-8FCDF4AE-F8F1-405B-8FDB-6F8E6EBF1046
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4348b9bfecc1351499192d9273e048bd3f660e13
P2860
Overall survival and updated results from a phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma.